Can psychedelic drugs treat depression? That’s the promise of findings from Robin Carhart-Harris, whose research is advancing a once fringe idea—that psychedelics, such as LSD or psilocybin, the active ingredient in magic mushrooms, might be able to treat some mental-health disorders, such as depression and anxiety—which is now making waves in mainstream medicine. Carhart-Harris leads Imperial College London’s Centre for Psychedelic Research, which became the world’s first center focused exclusively on studying how psychedelics can be used in mental-health care when it opened in 2019. His work has found that psilocybin, combined with psychotherapy, can be a fast-acting, powerful treatment for severe depression. “Psychedelics seem to reveal things within one’s psyche that are important and linked to why we are suffering, and they bring those things to the fore,” he says, adding that we’ve only scratched the surface of their therapeutic potential. —Mandy Oaklander
- Employers Take Note: Young Workers Are Seeking Jobs with a Higher Purpose
- Signs Are Pointing to a Slowdown in the Housing Market—At Last
- Welcome to the Era of Unapologetic Bad Taste
- As the Virus Evolves, COVID-19 Reinfections Are Going to Keep Happening
- A New York Mosque Becomes a Refuge for Afghan Teens Who Fled Without Their Families
- High Gas Prices are Oil Companies' Fault says Ro Khanna, and Democrats Should Go After Them
- Two Million Cases: COVID-19 May Finally Force North Korea to Open Up
